3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid

C29H32N6O5S — CID 146372346

IUPAC3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid
SMILESCC[C@@H]1CN(Cc2nc(C(CC(=O)O)c3ccc4c(nnn4C4CC4)c3C)ccc2C)S(=O)(=O)c2cccnc2O1
InChIInChI=1S/C29H32N6O5S/c1-4-20-15-34(41(38,39)26-6-5-13-30-29(26)40-20)16-24-17(2)7-11-23(31-24)22(14-27(36)37)21-10-12-25-28(18(21)3)32-33-35(25)19-8-9-19/h5-7,10-13,19-20,22H,4,8-9,14-16H2,1-3H3,(H,36,37)/t20-,22?/m1/s1
InChIKeyZQGOLQDXTLWXHR-PSDZMVHGSA-N
MW576.68 g/mol
LogP4.14
Rot. Bonds8

About 3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid

3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid (PubChem CID 146372346) has the molecular formula C29H32N6O5S and a molecular weight of 576.68 g/mol. Its IUPAC name is 3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid.

Molecular Properties

Compound Name3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid
PubChem CID146372346
Molecular FormulaC29H32N6O5S
Molecular Weight576.68 g/mol
Exact Mass576.22
IUPAC Name3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid
SMILESCC[C@@H]1CN(Cc2nc(C(CC(=O)O)c3ccc4c(nnn4C4CC4)c3C)ccc2C)S(=O)(=O)c2cccnc2O1
InChIInChI=1S/C29H32N6O5S/c1-4-20-15-34(41(38,39)26-6-5-13-30-29(26)40-20)16-24-17(2)7-11-23(31-24)22(14-27(36)37)21-10-12-25-28(18(21)3)32-33-35(25)19-8-9-19/h5-7,10-13,19-20,22H,4,8-9,14-16H2,1-3H3,(H,36,37)/t20-,22?/m1/s1
InChIKeyZQGOLQDXTLWXHR-PSDZMVHGSA-N
XLogP4.14
TPSA140.40 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds8
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500576.68
LogP ≤ 54.14
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze 3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid?
The IUPAC name of 3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid (CID 146372346) is 3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid.
What is the SMILES notation for 3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid?
The canonical SMILES for 3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid is CC[C@@H]1CN(Cc2nc(C(CC(=O)O)c3ccc4c(nnn4C4CC4)c3C)ccc2C)S(=O)(=O)c2cccnc2O1.
What is the InChIKey of 3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid?
The InChIKey is ZQGOLQDXTLWXHR-PSDZMVHGSA-N. The full InChI is InChI=1S/C29H32N6O5S/c1-4-20-15-34(41(38,39)26-6-5-13-30-29(26)40-20)16-24-17(2)7-11-23(31-24)22(14-27(36)37)21-10-12-25-28(18(21)3)32-33-35(25)19-8-9-19/h5-7,10-13,19-20,22H,4,8-9,14-16H2,1-3H3,(H,36,37)/t20-,22?/m1/s1.
What are the key properties of 3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid?
3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid has a molecular weight of 576.68 g/mol, XLogP of 4.14, 8 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(1-cyclopropyl-4-methylbenzotriazol-5-yl)-3-[6-[[(4R)-4-ethyl-1,1-dioxo-3,4-dihydropyrido[2,3-b][1,4,5]oxathiazepin-2-yl]methyl]-5-methyl-2-pyridinyl]propanoic acid is sourced from PubChem (CID 146372346), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).